Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Baxdrostat Alone and with Itraconazole in Healthy Participants
NCT06357520Phase 1Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2024
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of baxdrostat in hypertension (HTN), sponsored by AstraZeneca. Primary endpoints: Area Under Plasma Concentration-Time Curve From Time Zero To Infinity and Maximum Observed Plasma Drug Concentration. Started Apr 2024; status: completed.
02
Drugs
baxdrostat
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT06357520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06357520.